Key result
Chronic kidney disease was associated with a higher 10-year incidence of depression requiring antidepressant prescription compared to matched controls (9.0% vs 3.5%; HR 2.63, 95% CI 2.51-2.75).
Why the study?
Large population-based analyses evaluating the effect of CKD on the incidence of depression were lacking.
Does chronic kidney disease increase the incidence of depression requiring treatment?
Cohort (n=331,574)
Does chronic kidney disease increase the incidence of depression requiring treatment?
Hazard Ratio: 2.63 (95% CI 2.51–2.75)
Absolute Event Rate: 9% vs 3.5%
p-value: p=<.001
Chronic kidney disease is associated with a significantly higher incidence of depression requiring drug treatment, particularly in patients under 60 years of age.
May support closer depression monitoring in CKD; leaves open whether screening improves outcomes.
Background Depression is one of the most common psychiatric condition in patients with chronic kidney disease (CKD). It is associated with decreased adherence and quality of life as well as increased risk for dialysis, hospitalization, and mortality. Large population-based analysis evaluating the effect of CKD on the incidence of depression are missing. Methods We performed a retrospective cohort study investigating the incidence of depression after CKD diagnosis in a large cohort derived from the IQVIATM Disease Analyzer database. Patients with CKD were matched to individuals without CKD using the nearest neighbor propensity score matching method. The 10-year cumulative incidence of depression was compared between the cohorts using Kaplan–Meier curves and an univariable conditional Cox regression analysis was performed to assess the association between CKD and depression, as well as antidepressant prescription. Results Both cohorts included 165 787 individuals each, either with or without CKD. The 10-year incidence of depression was 24.2% in patients with CKD and 22.2% in patients without CKD (P < .001). The incidence of depression followed by an antidepressant prescription was 9.0% in the CKD cohort and 3.5% in the non-CKD cohort (P < .001), resulting in a hazard ratio (HR) of 2.63 (95% confidence intervals (CI) 2.51–2.75). This association was strongest in younger patients below 60 years of age (HR 6.03, 95% CI 5.17–7.01). Conclusion In this large cohort, CKD is associated with a slightly higher incidence of depression requiring drug treatment. Clinicians caring for patients with CKD, especially younger patients, should be aware of the increased risk.
No takes yet. Share an insight, caveat, or question.
Kommer et al. (2025) conducted a cohort in Chronic kidney disease (CKD) (n=331,574). Chronic kidney disease vs. Individuals without chronic kidney disease was evaluated on Incidence of depression followed by an antidepressant prescription (HR 2.63, 95% CI 2.51-2.75, p=<.001). Chronic kidney disease was associated with a higher 10-year incidence of depression requiring antidepressant prescription compared to matched controls (9.0% vs 3.5%; HR 2.63, 95% CI 2.51-2.75).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: